434 related articles for article (PubMed ID: 16040401)
21. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
Smeets PJ; Planavila A; van der Vusse GJ; van Bilsen M
Acta Physiol (Oxf); 2007 Nov; 191(3):171-88. PubMed ID: 17935522
[TBL] [Abstract][Full Text] [Related]
22. [PPARs: structure, mechanisms of action and control. Note I].
Filip-Ciubotaru F; Foia L; Manciuc C; Grigore C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):477-84. PubMed ID: 21870744
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance.
Patsouris D; Müller M; Kersten S
Curr Opin Investig Drugs; 2004 Oct; 5(10):1045-50. PubMed ID: 15535425
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury.
Cuzzocrea S
Vascul Pharmacol; 2004 Jul; 41(6):187-95. PubMed ID: 15653094
[TBL] [Abstract][Full Text] [Related]
25. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Gervois P; Fruchart JC; Staels B
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of PPARs: from molecular characterization to physiological relevance.
Diradourian C; Girard J; Pégorier JP
Biochimie; 2005 Jan; 87(1):33-8. PubMed ID: 15733734
[TBL] [Abstract][Full Text] [Related]
27. PPAR and Pain.
Maeda T; Kishioka S
Int Rev Neurobiol; 2009; 85():165-77. PubMed ID: 19607969
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptors and the metabolic syndrome.
Bragt MC; Popeijus HE
Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
Belvisi MG; Hele DJ; Birrell MA
Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
[TBL] [Abstract][Full Text] [Related]
30. [Autoimmune disease].
Yoshikawa T; Kawahito Y
Nihon Rinsho; 2005 Apr; 63(4):687-90. PubMed ID: 15828238
[TBL] [Abstract][Full Text] [Related]
31. Kinase signaling cascades that modulate peroxisome proliferator-activated receptors.
Gelman L; Michalik L; Desvergne B; Wahli W
Curr Opin Cell Biol; 2005 Apr; 17(2):216-22. PubMed ID: 15780600
[TBL] [Abstract][Full Text] [Related]
32. RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases.
van Neerven S; Kampmann E; Mey J
Prog Neurobiol; 2008 Aug; 85(4):433-51. PubMed ID: 18554773
[TBL] [Abstract][Full Text] [Related]
33. Immunoselection and characterization of a human genomic PPAR binding fragment located within POTE genes.
Murad H; Collet P; Brunner E; Schohn H; Bécuwe P; Devignes MD; Dauça M; Domenjoud L
Biochimie; 2007 Mar; 89(3):329-36. PubMed ID: 17070643
[TBL] [Abstract][Full Text] [Related]
34. Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: design, synthesis, and effects on cardiomyocyte differentiation.
Wei ZL; Petukhov PA; Bizik F; Teixeira JC; Mercola M; Volpe EA; Glazer RI; Willson TM; Kozikowski AP
J Am Chem Soc; 2004 Dec; 126(51):16714-5. PubMed ID: 15612696
[TBL] [Abstract][Full Text] [Related]
35. [Lipid nutrition and the epidermal barrier: The connection between immune-mediated inflammatory diseases and peroxisome proliferator-activated receptors, a new therapeutic target in psoriasis and atopic dermatitis].
Villarrubia VG; Vidal-Asensi S; Pérez-Bañasco V; Cuevas-Santos J; Cisterna-Cáncer R
Actas Dermosifiliogr; 2010 Sep; 101(7):585-99. PubMed ID: 20858385
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptors and retinoid X receptor-alpha in term human gestational tissues: tissue specific and labour-associated changes.
Holdsworth-Carson SJ; Permezel M; Riley C; Rice GE; Lappas M
Placenta; 2009 Feb; 30(2):176-86. PubMed ID: 19070893
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
Han S; Roman J
Anticancer Drugs; 2007 Mar; 18(3):237-44. PubMed ID: 17264754
[TBL] [Abstract][Full Text] [Related]
38. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.
Libby P; Plutzky J
Am J Cardiol; 2007 Feb; 99(4A):27B-40B. PubMed ID: 17307056
[TBL] [Abstract][Full Text] [Related]
39. PPAR: a therapeutic target in Parkinson's disease.
Chaturvedi RK; Beal MF
J Neurochem; 2008 Jul; 106(2):506-18. PubMed ID: 18384649
[TBL] [Abstract][Full Text] [Related]
40. Evolution of peroxisome proliferator-activated receptor agonists.
Chang F; Jaber LA; Berlie HD; O'Connell MB
Ann Pharmacother; 2007 Jun; 41(6):973-83. PubMed ID: 17519293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
